文献速递妇科

局部治疗改善IVB期宫颈癌患者生存

Local treatment improves survival in patients with stage IVB cervical cancer.
PubMed 文献 · Gynecol Oncol · 2022-04-27

基于监测、流行病学和最终结果(SEER)项目2010至2015年数据,纳入960例均接受化疗的IVB期宫颈癌患者,采用倾向性评分匹配和多因素Cox回归分析。局部治疗是改善肿瘤特异性生存(CSS)的独立预后因素,单纯放疗或手术±放疗均较无局部治疗改善CSS,单纯放疗与手术组间CSS无显著差异。

要点

  • 960例IVB期宫颈癌患者均接受化疗,818例(85.2%)接受局部治疗。
  • 局部治疗是改善肿瘤特异性生存(CSS)的独立预后因素。
  • 倾向性评分匹配前后,放疗或手术均较无局部治疗改善CSS。

核心结论

  • 在化疗基础上增加局部手术或放疗似乎可改善IVB期宫颈癌患者的生存结局。

研究设计与样本

  • 利用监测、流行病学和最终结果(SEER)项目数据,纳入2010至2015年诊断为IVB期宫颈癌的患者,共960例,所有患者均接受化疗。
  • 采用倾向性评分匹配(PSM)平衡患者的临床病理变量,并进行多因素Cox回归分析肿瘤特异性生存(CSS)相关危险因素。

主要发现

  • 818例(85.2%)患者接受局部治疗,其中724例(88.5%)接受单纯放疗,94例(11.5%)接受手术±放疗。
  • 倾向性评分匹配前,与无局部治疗相比,接受放疗(HR 0.633,95%CI 0.517-0.775,P<0.001)或手术(HR 0.391,95%CI 0.277-0.552,P<0.001)均与更好的CSS独立相关。
  • 无局部治疗组、单纯放疗组和手术组的3年CSS率分别为14.4%、32.4%和54.8%(P<0.001)。
  • 倾向性评分匹配后,与无局部治疗相比,放疗(HR 0.643,95%CI 0.436-0.947,P=0.025)和手术(HR 0.146,95%CI 0.052-0.410,P<0.001)均与更好的CSS相关。
  • 倾向性评分匹配后,单纯放疗组与手术组之间的CSS相似(HR 0.756,95%CI 0.454-1.260,P=0.284)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the value of local treatment in stage IVB cervical cancer (CC). METHODS: Patients diagnosed with stage IVB CC between 2010 and 2015 were included using the data from the Surveillance, Epidemiology, and End Results program. Propensity score matching (PSM) was used to balance the clinicopathological variables of patients. Multivariate Cox regression analyses were performed to analyze the risk factors associated with cause-specific survival (CSS). RESULTS: We identified 960 patients in this study, all patients had received chemotherapy. Of these patients, 818 patients were treated with local treatment (85.2%), including 724 (88.5%) and 94 (11.5%) patients receiving radiotherapy (RT) alone and surgery ± RT, respectively. Local treatment was the independent prognostic factor associated with better CSS. Before PSM, patients who received RT (hazard ratio [HR] 0.633, 95% confidence interval [CI] 0.517-0.775, P < 0.001) or surgery (HR 0.391, 95% CI 0.277-0.552, P < 0.001) were independently associated with a better CSS compared to those with no local treatment. The 3-years CSS rate was 14.4%, 32.4%, and 54.8% in no local treatment, RT alone, and surgery groups, respectively (P < 0.001). Similar results were found after PSM. Patients receiving RT (HR 0.643, 95% CI 0.436-0.947, P = 0.025) and surgery (HR 0.146, 95% CI 0.052-0.410, P < 0.001) had better CSS compared to patients with no local treatment after PSM. While similar CSS was shown between RT alone cohort and the surgery cohort (HR 0.756, 95% CI 0.454-1.260, P = 0.284). CONCLUSIONS: The addition of local surgery or RT to chemotherapy appears to confer improved survival outcomes in patients with stage IVB CC.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Xu JY, Chen JN, Lei J, et al. Local treatment improves survival in patients with stage IVB cervical cancer. Gynecol Oncol. 2022. PMID: 35490033. doi:10.1016/j.ygyno.2022.04.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。